Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.
From the official U.S. FDA label for glucose, the active ingredient registered with NAFDAC.
INDICATIONS For the temporary relief of excess sweating, increased hunger, fatigue, or lightheadedness.*
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Consult a doctor if condition worsens or if symptoms persist. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
If pregnant or breastfeeding, ask a healthcare professional before use.
Compare the brands and batch numbers in these notices with your pack, or enter your batch number above.
Add the expiry date on your pack for a full Trust Score.
Vamis Glucose contains Glucose (3.4 g), as chewable tablet, according to its NAFDAC registration record.
Yes. Vamis Glucose is listed on the NAFDAC register under registration number A4-2196, and its registration is active as of 28 October 2026.
No WHO falsified or substandard medical product alert currently matches Vamis Glucose in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number A4-2196, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
INDICATIONS For the temporary relief of excess sweating, increased hunger, fatigue, or lightheadedness.* (Summarised from the official U.S. FDA label for glucose. Always follow your doctor or pharmacist.)
Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.